相关实验视频

Updated: Sep 11, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

循环生物标志物作为内的潜在危险因素

Enke Baldini¹, Salvatore Sorrenti¹, Eleonora Lori¹

¹Department of Surgery, "Sapienza" University of Rome, 00185 Rome, Italy.

International journal of molecular sciences

|August 14, 2025

概括

该研究确定了前原I型N-终端 (PINP) 与前原III型N-终端 (PIIINP) 的比率是 inguinal 风险的关键预测因素. 这一比例反映了原代谢,为评估漏敏感性提供了一个新的分子生物标志物.

科学领域:

生物化学生物化学
分子生物学分子生物学
连接组织研究连接组织研究

背景情况:

在患者中观察到连接组织,特别是原的代谢变化.
像金属蛋白酶 (MMPs) 和 lysyl氧化酶 (LOX) 等酶和原蛋白生物合成都与的新陈代谢有关.
确定可靠的生物标志物用于风险评估对于早期干预至关重要.

研究的目的:

评估MMPs,LOX和原生物合成 (PINP,PIIINP,PIVNP) 的血度,作为 inguinal 风险的潜在生物标志物.
调查这些生物标志物,患者人口统计和的特征之间的关系.

主要方法:

分析了51名 inguinal 患者和42名健康对照者的血样本.
测试包括发热图和ELISA来量化MMP,LOX,PINP,PIIINP和PIVNP.
使用统计分析,包括回归和ROC分析,来确定生物标志物的显著性.

主要成果:

患者显示PINP降低和PIIINP水平增加,改变PINP/PIIINP比率.
PINP/PIIINP比率与风险相反相关,切线为0.948,显示出高灵敏度和特异性.
血MMP-9在患者中降低;MMP-2在患有的家族病史的人中较低.

结论:

PINP/PIIINP比率是估计 inguinal 风险的一个重要的分子预测指标.
这一比率可以作为一种有价值的生物标志物,用于识别容易患上 inguinal hernias 的个体.
进一步的研究可以探索这种比率在预防策略中的临床实用性.

关键词:

类型I (PINP) 和类型III (PIIINP) 的N终端类型的公聚物.原蛋白是一种原蛋白.inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia inguinal hernia lysyl 氧化酶的作用是什么金属蛋白酶类的金属蛋白质.

更多相关视频

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...